Clinical trial
A Pilot Study to Evaluate the Use of the MN4000 for Treatment of Cystic Fibrosis (CF) and Motor Neuron Disease (MND) Patients in the Home Setting
NCT03797677 is registered in ClinicalTrials.gov with Hill-Rom as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate the Use of the MN4000 for Treatment of Cystic Fibrosis (CF) and Motor Neuron Disease (MND) Patients in the Home Setting
- Lead sponsor
- Hill-Rom
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 9, 2017
- Completion date
- November 30, 2017
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
airway clearance impairment, cystic fibrosis, motor neuron disease